Market News AIOpen the app

ANGO stock news · AngioDynamics, Inc.

Stories about AngioDynamics, Inc. (ANGO) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for ANGO

Follow AngioDynamics, Inc. (ANGO) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ANGO
Free on the App Store and Google Play, or on the web.
  1. Oct 8, 2026, 7:21 AM ET · New boss

    AngioDynamics, Inc. says it has a new important agreement as Eric Honroth becomes President and CEO.

    Neutral

    AngioDynamics named Eric Honroth as its next CEO. His medical-device experience may help, but the filing reports no change to the business, so the company's outlook remains unchanged.

  2. Oct 8, 2026, 7:21 AM ET · Market

    AngioDynamics, Inc. shares how they did financially in the first quarter ending August 31, 2026.

    Neutral

    AngioDynamics filed a notice about first-quarter results, but the supplied text gives no sales or profit figures. It reports no specific change in the company's business.

  3. Oct 8, 2026, 7:17 AM ET · Results

    Companies will share their earnings on October 8, 2026.

    Neutral

    AngioDynamics is listed with an expected quarterly loss of $0.11 per share and $81 million in sales. These are estimates, not results, and there is no comparison with earlier results.